Metagenomi Therapeutics MGX Growth Metrics (2023-2026)

NASDAQ MGX
$1.20 -0.04 (-3.23%)
At close: Aug 20, 2026 · 4:00 PM EDT
Growth Metrics Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
EBITDA Margin Growth (1y) (Quarter) -5296.007,416.00-1325.00-5163.00-41393.00-16225.00-6936.00-40853.00-129601.00
EBITDA Margin Growth (3y) (Quarter) -176290.00
EBITDA Margin (QoQ) (Quarter) 4,876.00-2270.001,826.00-9728.0017,589.00-11012.00-2011.00-45959.0042,757.00-1723.00-35928.00-134707.00
EBIT Margin Growth (1y) (Quarter) -5296.007,416.00-1325.00-5163.00-41393.00-16225.00-6936.00-40853.00-129601.00
EBIT Margin Growth (3y) (Quarter) -176290.00
EBIT Margin (QoQ) (Quarter) 4,876.00-2270.001,826.00-9728.0017,589.00-11012.00-2011.00-45959.0042,757.00-1723.00-35928.00-134707.00
EBT Margin Growth (1y) (Quarter) -6438.003,333.00-3077.00-12232.00-37898.00-16867.00-5688.00-31921.00-124254.00
EBT Margin Growth (3y) (Quarter) -168590.00
EBT Margin (QoQ) (Quarter) 6,298.00-5256.001,694.00-9174.0016,070.00-11667.00-7460.00-34840.0037,100.00-488.00-33693.00-127173.00
Enterprise Value Growth (1y) (Quarter) -242.21%-480.70%-169.48%8.44%30.98%31.65%32.95%35.24%37.97%41.14%
Enterprise Value Growth (3y) (Quarter) -13.57%-32.69%
Enterprise Value (QoQ) (Quarter) 46.02%-97.29%-166.13%-20.73%8.39%8.45%9.57%9.00%9.28%10.19%12.66%12.83%13.91%
FCF Margin Growth (1y) (Quarter) -1226.0013,406.00-3583.00-17070.00-28921.00-11628.00-25.00-32744.00-114620.00
FCF Margin Growth (3y) (Quarter) -144767.00
FCF Margin (QoQ) (Quarter) -992.005,868.0010,413.00-16516.0013,640.00-11121.00-3074.00-28367.0030,933.00482.00-35792.00-110243.00
Interest Coverage Ratio Growth (1y) (Quarter) 26.68%-29.28%-102.27%-7,863,435.62%-2,171.81%-2,446.88%
Interest Coverage Ratio (QoQ) (Quarter) -1,668.69%42.52%-3,018.40%10.07%-87,503.73%-220.07%99.10%-0.82%
Net Margin Growth (1y) (Quarter) -3900.006,107.00-273.00-8776.00-38135.00-18018.00-7247.00-33264.00-124096.00
Net Margin Growth (3y) (Quarter) -166132.00
Net Margin (QoQ) (Quarter) 7,162.00-4558.00471.00-6975.0017,169.00-10937.00-8033.00-36334.0037,286.00-166.00-34050.00-127166.00
Operating Margin Growth (1y) (Quarter) -5296.007,416.00-1325.00-5163.00-41393.00-16225.00-6936.00-40853.00-129601.00
Operating Margin Growth (3y) (Quarter) -176290.00
Operating Margin (QoQ) (Quarter) 4,876.00-2270.001,826.00-9728.0017,589.00-11012.00-2011.00-45959.0042,757.00-1723.00-35928.00-134707.00
Return on Assets Growth (1y) (Quarter) 0.000.000.000.000.000.00
Return on Assets (QoQ) (Quarter) 0.000.000.000.000.000.000.000.000.00
Return on Capital Employed Growth (1y) (Quarter) -427.00-1102.00-1292.00-1615.00-1742.00-2731.00
Return on Capital Employed (QoQ) (Quarter) 261.00-166.00-212.00-309.00-414.00-356.00-535.00-436.00-1403.00
Return on Sales Growth (1y) (Quarter) -1.001.000.00-1.00-4.00-2.00-1.001.00-12.00
Return on Sales Growth (3y) (Quarter) -17.00
Return on Sales (QoQ) (Quarter) 0.000.000.00-1.002.00-1.00-1.00-4.004.000.001.00-17.00